Hosted on MSN3mon
Biotech Stock Roundup: Updates From GILD, REGN, GSK, ANAB Down on Study Data, EWTX GainsThe Committee for Medicinal Products for Human Use (“CHMP”) of ... ANAB will discontinue further investment in this asset. GSK’s HIV subsidiary, ViiV Healthcare, announced that the CHMP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback